IκBα overexpression delays tumor formation in v-rel transgenic mice

Journal of Experimental Medicine

Volumn 186, Issue 2, 1997, Pages 279-288

  Carrasco, Daniel ^a   Perez, Paloma ^a   Lewin, Anne ^a   Bravo, Rodrigo ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; DNA; DNA BINDING PROTEIN; I KAPPA B; INTERCELLULAR ADHESION MOLECULE 1; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; GENE OVEREXPRESSION; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL LYMPHOMA; TRANSGENIC MOUSE; ANIMAL; CHEMISTRY; CUTANEOUS T CELL LYMPHOMA; FLOW CYTOMETRY; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; PHYSIOLOGY;

ANIMALS; DNA; DNA-BINDING PROTEINS; FLOW CYTOMETRY; I-KAPPA B PROTEINS; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTES; LYMPHOMA, T-CELL; LYMPHOMA, T-CELL, CUTANEOUS; MICE; MICE, TRANSGENIC; ONCOGENE PROTEINS V-REL; RETROVIRIDAE PROTEINS, ONCOGENIC;

EID: 0030610846     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.2.279     Document Type: Article

References (40)

1. Bose, H.R. 1992. The Rel family : models tor transcriptional regulation and oncogenic transformation. Biochim. Biophys. Acta. 1114:1-17.
2. Enrietto, P.J. 1990. The rel gene and its role in oncogenesis. Semin. Cancer Biol. 1:399-405.
3. Gilmore, T.D. 1991. Malignant transformation by mutant Rel proteins. TIG (Trends Genet.). 7:318-322.
4. Gilmore, T.D. 1992. Role of rel family genes in normal and malignant lymphoid cell growth. Cancer Surv. 15:69-87.
5. Gilmore, T.D., M. K. Doedood, K.A. Piffat, and D.W. White. 1996. Rel/NF-κB/IκB proteins and cancer. Oncogene. 13: 1367-1378.
6. Baeuerle, P.A., and D. Baltimore. 1996. NF-κB: ten years after. Cell. 87:13-20.
7. Baeuerle, P.A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12: 141-179.
8. Finco, T.S., and A.S. Baldwin. 1995. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity. 3:263-272.
9. Griffi, M., J.-S. Chiu, and M.J. Lenardo. 1993. NF-κB and Rel-participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1-62.
10. Kopp, E.B., and S. Ghosh. 1995. NF-κB and Rel proteins in innate immunity. Adv. Immunol. 58:1-27.
11. Miyamoto, S., and I.M. Verma. 1995. Rel/NF-κB story. Adv. Cancer Res. 66:255-292.
12. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10: 405-455.
13. Baldwin, A.S. 1996. The NFκB and Iκβ proteins, new discoveries and insights. Annu. Rev. Immunol. 14:649-681.
14. Beg, A.A., and A.S. Baldwin, Jr. 1993. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev. 7:2064-2070.
15. Gilmore, T.D., and P.J. Morin. 1993. The IκB proteins: members of a multifunctional family. TIG (Trends Genet.). 9: 427-433.
16. Verma, I.M., J.K. Stevenson, E.M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
17. Carrasco, D., C.A. Rizzo, K. Dorfman, and R. Bravo. 1996. The v-rel oncogene promotes malignant T-cell leukemia/ lymphoma in transgemc mice. EMBO (Eur. Mol. Biol. Organ.) J. 15:3640-3650.
18. Beauparlant, P., I. Kwan, R. Bitar, P. Chou, A.E. Koromilas, N. Sonenberg, and J. Hiscott. 1994. Disruption of IκBα regulation by antisense RNA expression leads to malignant transformation. Oncogene. 9:3189-3197.
19. Perez, P., S.A. Lira, and R. Bravo. 1995. Overexpression of RelA in transgenic mouse thymocytes: specific increase on levels of the inhibitor IκBα. Mol. Cell. Biol. 15:3523-3530.
20. Carrasco, D., F. Weih, and R. Bravo. 1994. Developmental expression of the mouse c-rel protooncogene in hematopoietic organs. Development (Camb.). 120:2991-3004.
21. Weih, F., D. Carrasco, S.K. Durham, D.S. Barton, C.A. Rizzo, R.-P. Ryseck, S.A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/ Rel family. Cell. 80:331-340.
22. Weih, F., D. Carrasco, and R. Bravo. 1994. Constitutive and inducible Rel/NF-κB activities in mouse thymus and spleen. Oncogene. 9:3289-3297.
23. Diamandidou, E., P.R. Cohen, and R. Kurzrock. 1996. Mycosis fungoides and Sezary syndrome. Blood. 88:2385-2409.
24. Fivenson, D.P., C.A. Hanson, and B.J. Nickoloff. 1994. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma. J. Am. Acad. Dermatol. 31:717-723.
25. Lutzner, M., R. Edelson, P. Schein, I. Green, C. Kirkpatrick, and A. Ahmed. 1975. Cutaneous T-cell lymphomas: the sezary syndrome, mycosis fungoides, and related disorders. Ann. Intern. Med. 83:534-552.
26. Schein, P.S., J.S. Macdonald, and R. Edelson. 1976. Cutaneous T-cell lymphoma. Cancer (Phila.). 38:1859-1861.
27. IκB-β inhibition of DNA binding by rel proteins. Mol. Cell. Biol. 13:1769-1778.
28. Fukudome, K., M. Furuse, N. Fukuhara, S. Orita, T. Imai, S. Takagi, M. Nagira, Y. Hinuma, and O. Yoshie. 1992. Strong induction of ICAM-1 in human T cells transformed by human T-cell-leukemia virus type 1 and depression of ICAM-1 or LFA-1 in adult T-cell-leukemia-derived cell lines. Int. J. Cancer. 52:418-427.
29. Singer, K.H., P.T. Le, S.M. Denning, L.P. Whichard, and B.F. Haynes. 1990. The role of adhesion molecules in epithelial-T-cell interactions in thymus and skin. J. Invest. Dermatol. 94:85S-90S.
30. van de Stolpe, A., and P.T. van der Saag. 1996. Intercellular adhesion molecule-1. J. Mol. Med. 74:13-33.
31. Beg, A.A., W.C. Sha, R.T. Bronson, and D. Baltimore. 1995. Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκBα-deficient mice. Genes Dev. 9:2736-2746.
32. Klement, J.F., N.R. Rice, B.D. Car, S.J. Abbondanzo, G.D. Powers, H. Bhatt, C.-H. Chen, C.A. Rosen, and C.L. Stewart. 1996. IκBγ deficiency results in a sustained NF-κB response and severe widespread dermatitis in mice. Mol. Cell. Biol. 16:2341-2349.
33. Weih, F., S.A. Lira, and R. Bravo. 1996. Overexpression of RelB in transgenic mice does not affect IκBα levels: differential regulation of RelA and RelB by the inhibitor protein. Oncogene. 12:445-450.
34. Maio, M., A. Pinto, A. Carbone, V. Zagonel, A. Gloghini, G. Marotta, D. Cirillo, A. Colombatti, F. Ferrara, and L. Del Vecchio. 1990. Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lympho-proliferative disorders. Blood. 76:783-790.
35. Neri, A., N.S. Fracchiolla, E. Rosecetti, S. Garatti, D. Trecca, A. Boletini, B. Perletti, L. Bardini, A.T. Maiolo, and E. Berti. 1995. Molecular analysis of cutaneous B-and T-cell lymphomas. Blood. 86:3160-3172.
36. Chang, C.-C., J. Zhang, L. Lombardi, A. Neri, and R. Dalla-Favera. 1994. Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10. Oncogene. 9:923-933.
37. Chang, C.-C., J. Zhang, L. Lombardi, A. Neri, and R. Dalla-Favera. 1995. Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators. Mol. Cell. Biol. 15:5180-5187.
38. Fracchiolla, N.S., L. Lombardi, M. Salina, A. Migliazza, L. Baldini, E. Berti, L. Cro, E. Polli, AT. Maiolo, and A. Neri. 1993. Structural alterations of the NF-κB transcription factor lyt-10 in lymphoid malignancies. Oncogene. 8:2839-2845.
39. Thakur, S., H.-C. Lin, W.-T. Tseng, S. Kumar, R. Bravo, F. Foss, C. Gélinas, and A.B. Rabson. 1994. Rearrangement and altered expression of the NFKB-2 gene in human cutaneous T-lymphoma cells. Oncogene. 9:2335-2344.
40. Zhang, J., C.-C. Chang, L. Lombardi, and R. Dalla-Favera. 1994. Rearranged NFKB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions. Oncogene. 9:1931-1937.